About UsCoverage of IDWeek 2017
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of IDWeek 2017, held October 4-8, 2017, in San Diego.
- Long-Acting Monoclonal Antibody Effective Against Multidrug-Resistant HIV
- Single-Tablet Protease Inhibitor Regimen Maintains Viral Suppression for a Year
11/30/17
Many Americans Still Get HIV Diagnosis Years After Infection, CDC Says
- Details
- Category: HIV Testing & Diagnosis
- Published on Wednesday, 29 November 2017 00:00
- Written by Liz Highleyman
Many people with HIV in the United States are still being diagnosed with HIV late, and therefore are not getting the full therapeutic and prevention benefits of starting antiretroviral therapy (ART) early, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC), released in advance of World AIDS Day.
EACS 2017: HIV Diagnoses in English Gay Men Have Been Falling Since 2014
- Details
- Category: HIV Prevention
- Published on Thursday, 09 November 2017 00:00
- Written by Gus Cairns
A new analysis by Public Health England of testing rates and HIV diagnoses from all of England’s sexual health clinics shows that the decline in diagnoses is England-wide, started at least a year before the decline was first noticed at London's 56 Dean Street clinic, and is not restricted to gay men who test frequently.
EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines
- Details
- Category: Search for a Cure
- Published on Friday, 17 November 2017 00:00
- Written by Gus Cairns
A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, speakers said at a recent seminar on European HIV cure research. The STEPS seminar, put on by the European AIDS Treatment Group (EATG) ahead of the European AIDS Conference in Milan in October, also heard that, in the words of EATG member and European Community Advisory Board chair Giulio Maria Corbelli, "Cure research reminds us of the importance of patient involvement from the very earliest phases of the development of treatment and prevention."
EACS 2017: High HIV Incidence from Non-Primary Partners and Low PEP and PrEP Use Seen in PARTNER Study
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 07 November 2017 00:00
- Written by Gus Cairns
HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside their main relationship, was high, and very high among partners who admitted having condomless anal sex with non-primary partners, researchers reported at the recent 16th European AIDS Conference (EACS 2017) in Milan.
EACS 2017: Up to a Quarter of HIV-Negative Gay Men Attending 3 English Clinics Used PrEP in the Last Year
- Details
- Category: HIV Prevention
- Published on Tuesday, 14 November 2017 00:00
- Written by Gus Cairns
A prospective cohort study of gay men attending 3 clinics in southern England --56 Dean Street and Mortimer Market Centre in London and the Brighton & Hove SHAC (Sexual Health & Contraception) service -- have found that 23% of HIV-negative service users who responded to a follow-up questionnaire had used PrEP (pre-exposure prophylaxis) in the last year. These interim results from the AURAH2 study were presented recently at the 16th European AIDS Conference (EACS 2017) in Milan.
EACS 2017: Swiss Study Examines When Gay Men Decided to Stop Consistent Condom Use
- Details
- Category: HIV Sexual Transmission
- Published on Sunday, 05 November 2017 00:00
- Written by Gus Cairns
An innovative study presented at the 16th European AIDS Conference (EACS 2017) in Milan in October used a machine-learning algorithm (originally developed to help astronomers classify galaxies) to tease out whether there were specific groups of gay men within a large national cohort whose sexual risk behaviors followed similar trajectories over time, and if so, whether they were influenced by external factors such as new scientific data.
Coverage of the 16th European AIDS Conference
- Details
- Category: HIV Treatment
- Published on Tuesday, 14 November 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com and NAM coverage of the 16th European AIDS Conference (EACS 2017), October 25-27 2017, in Milan.
EACS 2017: Survey of Dating App Users Finds that PrEP Usage Has Not Increased in Europe in the Last Year
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 02 November 2017 00:00
- Written by Gus Cairns
A study of men who have sex with men (MSM) conducted by the European Centre for Disease Prevention and Control (ECDC) in collaboration with the gay contact site Hornet has found that pre-exposure prophylaxis (PrEP) usage has not increased, on average, among its respondents over the proportion reported last year, when a similar survey was carried out. The results were presented recently at the 16th European AIDS Conference (EACS 2017) in Milan.
Web Design and Development by